Largest biotech companies in the United States by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 20 biotech companies in the United States ranked by total assets, at ZAR 1.58T, ahead of Gilead Sciences (ZAR 1.03T) and Biogen (ZAR 513.1B). Figures as of 20 Nov 2026, 14:00 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- AmgenZAR 1.58T
- Median
- ZAR 42.5B
- Combined market value
- ZAR 12.81T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | ZAR 1.58T | ZAR 4.14T | ZAR 7,648.08 | 1.14% down | 30% up | ||
| 2 | Gilead SciencesGILD · Health Care | ZAR 1.03T | ZAR 3.6T | ZAR 2,902.41 | 1.45% down | 31% up | ||
| 3 | BiogenBIIB · Health Care | ZAR 513.1B | ZAR 636.7B | ZAR 4,307.16 | 1.70% down | 41% up | ||
| 4 | ModernaMRNA · Health Care | ZAR 215B | ZAR 1.41T | ZAR 3,474.07 | 1.29% up | 740% up | ||
| 5 | Neurocrine BiosciencesNBIX · Health Care | ZAR 80.7B | ZAR 276.2B | ZAR 2,729.16 | 3.85% down | 10% up | ||
| 6 | VaxcytePCVX · Health Care | ZAR 52.3B | ZAR 161B | ZAR 1,017.14 | 0.27% down | 22% up | ||
| 7 | RepligenRGEN · Health Care | ZAR 51.4B | ZAR 189.7B | ZAR 2,967.94 | 1.38% down | 5% up | ||
| 8 | ExelixisEXEL · Health Care | ZAR 49.6B | ZAR 280B | ZAR 1,147.33 | 3.60% down | 55% up | ||
| 9 | Bio-TechneTECH · Health Care | ZAR 45.1B | ZAR 199B | ZAR 1,267.07 | 0.07% down | 18% up | ||
| 10 | Halozyme TherapeuticsHALO · Health Care | ZAR 44B | ZAR 184.9B | ZAR 1,621.57 | 2.88% down | 32% up | ||
| 11 | Revolution MedicinesRVMD · Health Care | ZAR 41B | ZAR 601B | ZAR 2,778.66 | 0.24% down | 125% up | ||
| 12 | Kymera TherapeuticsKYMR · Health Care | ZAR 30.4B | ZAR 177.6B | ZAR 2,080.82 | 1.44% down | 81% up | ||
| 13 | Krystal BiotechKRYS · Health Care | ZAR 23.2B | ZAR 163.1B | ZAR 5,504.34 | 0.15% up | 49% up | ||
| 14 | ImmunovantIMVT · Health Care | ZAR 16.7B | ZAR 117.3B | ZAR 566.78 | 1.96% down | 44% up | ||
| 15 | CG OncologyCGON · Health Care | ZAR 13.8B | ZAR 127.5B | ZAR 1,427.41 | 2.38% up | 93% up | ||
| 16 | Twist BioscienceTWST · Health Care | ZAR 11.2B | ZAR 132.6B | ZAR 1,945.39 | 4.07% down | 291% up | ||
| 17 | Adaptive BiotechnologiesADPT · Health Care | ZAR 8.9B | ZAR 79.1B | ZAR 488.88 | 1.44% down | 51% up | ||
| 18 | ImmunityBioIBRX · Health Care | ZAR 8.7B | ZAR 121.8B | ZAR 114.51 | 1.94% down | 216% up | ||
| 19 | Scholar Rock HoldingSRRK · Health Care | ZAR 7B | ZAR 107.1B | ZAR 877.89 | 4.94% up | 25% up | ||
| 20 | Kodiak SciencesKOD · Health Care | ZAR 6.1B | ZAR 111.6B | ZAR 1,706.27 | 0.09% up | 371% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.4287 ZAR).
Questions and answers
Which biotech companies in the United States rank first by total assets?
Amgen (ZAR 1.58T), Gilead Sciences (ZAR 1.03T) and Biogen (ZAR 513.1B) are the top three of the 20 biotech companies in the United States ranked by total assets as of 20 Nov 2026, 14:00 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by total assets.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by total assets have a combined market value of ZAR 12.81T as of 20 Nov 2026, 14:00 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies in the United States by total assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.